Clincosm LogoSign in Get a demo

advanced malignant mesothelioma

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Mesothelioma Trial in Shanghai (HMPL-453)

Recruiting
  • Advanced Malignant Mesothelioma
  • Shanghai, China
    Shanghai Chest Hospital
Jun 12, 2020

Advanced Malignant Mesothelioma, Carcinoma of the Appendix, Ovarian Sarcoma Trial in Winston-Salem (HIPEC Orientation,

Completed
  • Advanced Malignant Mesothelioma
  • +15 more
  • HIPEC Orientation
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma Trial in Duarte (belinostat,

Completed
Has Results
  • Advanced Malignant Mesothelioma
  • +3 more
  • Duarte, California
    City of Hope
May 4, 2018

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma Trial in San Antonio (cediranib

Completed
Has Results
  • Advanced Malignant Mesothelioma
  • +3 more
  • cediranib maleate
  • laboratory biomarker analysis
  • San Antonio, Texas
    Southwest Oncology Group
Dec 27, 2017

Advanced Malignant Mesothelioma, Localized Malignant Mesothelioma, Recurrent Malignant Mesothelioma Trial in Rochester

Completed
Has Results
  • Advanced Malignant Mesothelioma
  • +2 more
  • laboratory biomarker analysis
  • pazopanib hydrochloride
  • Rochester, Minnesota
    North Central Cancer Treatment Group
Jan 28, 2015

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Localized Malignant Mesothelioma Trial in Chicago (cediranib maleate)

Completed
Has Results
  • Advanced Malignant Mesothelioma
  • +4 more
  • cediranib maleate
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jul 25, 2014

Advanced Malignant Mesothelioma, Recurrent Malignant Mesothelioma Trial in Kingston (sunitinib malate)

Completed
Has Results
  • Advanced Malignant Mesothelioma
  • Recurrent Malignant Mesothelioma
  • sunitinib malate
  • Kingston, Ontario, Canada
    National Cancer Institute of Canada Clinical Trials Group
May 5, 2014

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Localized Malignant Mesothelioma Trial in Chicago (drug, biological,

Completed
  • Advanced Malignant Mesothelioma
  • +4 more
  • gemcitabine hydrochloride
  • +4 more
  • Chicago, Illinois
    University of Chicago
Feb 10, 2014

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma Trial (biological, drug, other)

Withdrawn
  • Advanced Malignant Mesothelioma
  • +3 more
  • rilotumumab
  • +3 more
  • (no location specified)
Aug 1, 2013

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma Trial in San Antonio (erlotinib HCl,

Completed
  • Advanced Malignant Mesothelioma
  • +3 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • San Antonio, Texas
    Southwest Oncology Group
Jan 23, 2013

Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma Trial in Chicago (gefitinib,

Completed
  • Advanced Malignant Mesothelioma
  • +3 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013

Advanced Malignant Mesothelioma, Localized Malignant Mesothelioma, Malignant Ascites Trial in Philadelphia (drug, procedure,

Terminated
  • Advanced Malignant Mesothelioma
  • +4 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jan 15, 2013